Cipla may drop on weak Q4 results

Cipla reported consolidated net loss of Rs 61.79 crore in Q4 March 2017 compared with loss of Rs 92.83 crore in Q4 March 2016. Total income rose 6.84% to Rs 3604.79 crore in Q4 March 2017 over Q4 March 2016. The result was announced after market hours yesterday, 25 May 2017.

ITC, Tech Mahindra and Sun Pharmaceutical Industries will announce Q4 results today, 26 May 2017.

Tata Power Renewable Energy, a wholly owned subsidiary of Tata Power company has successfully issued Guaranteed, Unsecured, Non-Cumulative, Redeemable, Taxable, Listed, Rated Non-Convertible Debentures of Rs 500 crore on private placement basis. The announcement was made after market hours yesterday, 25 May 2017.

Infosys and HP Inc. yesterday, 25 May 2017 launched joint Retail Point of Sale (RPOS) and Enterprise Device as a Service (DaaS) solutions to help businesses accelerate digital transformation as part of the HP Global System Integrator (GSI) Alliance Program. The announcement was made after market hours yesterday, 25 May 2017.

The joint RPOS solution offers a digital approach across the supply chain, enabling real-time collaboration between shoppers, retailers and vendors at the point of purchase, providing a true omnichannel experience. The joint Enterprise Device as a Service solution defines and delivers technologyenabled transformations that optimize how organizations acquire, manage and use devices with end-to-end services, enterprise applications, fleet reporting, analytics, insights and more.

TTK Prestige announced that the board of directors of the company in a meet on 30 May 2017 will consider share buyback. The announcement was made after market hours yesterday, 25 May 2017.

NMDC's net profit rose 11.5% to Rs 511.88 crore on 87.69% rise in total income from operations to Rs 2871.98 crore in Q4 March 2017 over Q4 March 2016. The announcement was made after market hours yesterday, 25 May 2017.

HeidelbergCement India's net profit rose 49.25% to Rs 37.03 crore on 14.05% rise in total income to Rs 542.38 crore in Q4 March 2017 over Q4 March 2016. The result was announced after market hours yesterday, 25 May 2017.

UPL and Sinagro Group, a Brazilian company in the state of Matto Grosso, comprising of (i) Sinagro Produtos Agropecuios S.A and (ii) 3SB Produtos Agrolas S.A. has obtained necessary approval for an agreement and has consequentially completed a transaction in terms of the agreement in which UPL through its step down wholly owned subsidiary has subscribed to additional 9% shares in Sinagro Group, so as to increase its interest in the Sinagro Group share capital from 40% to 49%. Sinagro Group based out of Primavera de Leste in the state of Mato Grosso, is one of the leading distributors of farm inputs in the Cerrado region of Brazil and is also in the business of agricultural production and trading of grains. The announcement was made after market hours yesterday, 25 May 2017.

Glenmark Pharmaceuticals Inc., USA has been granted final approval by the United States Food & Drug Administration (USFDA) for Olmesartan Medoxomil Tablets, 5 mg, 20 mg and 40 mg, the generic version of Benicar Tablets, 5 mg, 20 mg and 40 mg, of Daiichi Sankyo, Inc. Glenmark's Olmesartan Medoxomil Tablets will be manufactured by Glenmark Pharmaceuticals in its manufacturing facility located in Goa, India.

According to IMS Health sales data for the 12 month period ended March 2017, the Benicar Tablets, 5 mg, 20 mg and 40 mg market achieved annual sales of approximately $950.0 million in US. The announcement was made before market hours today, 26 May 2017.

Mphasis and DXC Technology announced a new solution partner relationship to tranform and modernize enterprise applications for public, private and hybrid cloud. The announcement was made before market hours today, 26 May 2017.

Powered by Capital Market - Live News